Summit Wealth Group (Colorado)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Summit Wealth Group (Colorado)'s ABBV Position: Q2 2026 in Review
Summit Wealth Group (Colorado) increased its AbbVie (ABBV) stake by 9.9% in Q2 2026, buying an estimated $61.5K and bringing the position to 3,165 shares worth $797K. The position accounts for 0.07% of the portfolio, ranked #154.
Summit Wealth Group (Colorado) first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. 1,977 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Summit Wealth Group (Colorado) held 3,165 shares of AbbVie worth $797K as of Q2 2026.
- Summit Wealth Group (Colorado) bought 286 AbbVie shares in Q2 2026, an estimated $61.5K.
- AbbVie made up 0.07% of Summit Wealth Group (Colorado)'s portfolio in Q2 2026, its #154 holding.
- Summit Wealth Group (Colorado) first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
- 1,977 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Summit Wealth Group (Colorado)'s 13F filing for Q2 2026, filed 28 Jul 2026.